Clinical Trial
2016 Jul;31(3):196-209.
JOURNAL：Cardiovasc Interv Ther.
Article Link
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial
Natsuaki M, Morimoto T, Kimura T et al.
KEYWORDS
Coronary artery disease; Coronary stent; Dual antiplatelet therapy; Everolimus-eluting stent
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
